N-(toluene-4-sulfonyl)-L-[1,1-dioxo)thiamorpholin-3-carbonyl]-L-4-(N,N-dimethylcarbamyloxy)phenylalanine

ID: ALA3938571

Chembl Id: CHEMBL3938571

PubChem CID: 134148355

Max Phase: Preclinical

Molecular Formula: C24H29N3O9S2

Molecular Weight: 567.64

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2CCS(=O)(=O)C[C@@H]2C(=O)N[C@@H](Cc2ccc(OC(=O)N(C)C)cc2)C(=O)O)cc1

Standard InChI:  InChI=1S/C24H29N3O9S2/c1-16-4-10-19(11-5-16)38(34,35)27-12-13-37(32,33)15-21(27)22(28)25-20(23(29)30)14-17-6-8-18(9-7-17)36-24(31)26(2)3/h4-11,20-21H,12-15H2,1-3H3,(H,25,28)(H,29,30)/t20-,21+/m0/s1

Standard InChI Key:  KGKLYWUBSSOGFT-LEWJYISDSA-N

Alternative Forms

  1. Parent:

    ALA3938571

    ---

Associated Targets(Human)

ITGAL Tclin Integrin alpha-L/beta-2 (LFA-1) (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin ITGB1-ITGA9 complex (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 567.64Molecular Weight (Monoisotopic): 567.1345AlogP: 0.66#Rotatable Bonds: 8
Polar Surface Area: 167.46Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.87CX Basic pKa: CX LogP: 0.73CX LogD: -2.76
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.47Np Likeness Score: -1.20

References

1.  (2003)  Alpha-9 integrin antagonists and anti-inflammatory compositions therof, 

Source